31
October 2024
Spire Healthcare Group
plc
Share Buyback
Programme
Spire Healthcare Group plc (LSE:
SPI) ("Spire Healthcare" or "Company"), a leading independent
healthcare group in the United Kingdom, announces a return of up to
£5m cash to its shareholders through the means of an on-market
share buyback programme (the "Programme").
Spire Healthcare has entered into a
non-discretionary arrangement with Numis Securities Limited,
trading as Deutsche Numis, to conduct the Programme on its behalf
commencing today, 31 October 2024, and ending no later than 31
December 2024. Under these arrangements, Deutsche Numis will
conduct the repurchases of the Company's ordinary shares of 1 pence
each (the "Ordinary Shares") up to a maximum aggregate
consideration of £5m and will make trading decisions in relation to
the buyback of the Ordinary Shares within the programme terms and
pre-set parameters.
The sole purpose of the Programme is
to reduce the issued share capital of the Company, delivering
further value for shareholders, and any Ordinary Shares purchased
under the Programme will be cancelled.
The Programme will be conducted by
the Company in accordance with and under the terms of the general
authority granted by the Company's shareholders at the Company's
Annual General Meeting on 9 May 2024, pursuant to which the Company
has authority to purchase a maximum of 40,413,223 Ordinary Shares
(subject to certain limitations) (the "General Authority"). The
aggregate number of Ordinary Shares which may be acquired by the
Company pursuant to the Programme will not exceed the maximum
number of Ordinary Shares which the Company is authorised to
purchase pursuant to the General Authority.
Any purchase of Ordinary Shares made
in relation to the Programme will be carried out on the London
Stock Exchange. The buyback by Spire Healthcare will be executed in
accordance with Chapter 9 of the UK Listing Rules and the terms of
the General Authority. The Programme will be conducted within the
parameters prescribed by the Market Abuse Regulation (EU) 596/2014,
the Commission Delegated Regulation (EU) 2016/1052 (both as
incorporated into UK domestic law by the European Union
(Withdrawal) Act 2018) and with regard to regulatory technical
standards for the conditions applicable to buy-back programmes and
stabilisation measures.
Spire Healthcare will announce any
purchase by it of Ordinary Shares no later than 7.30 a.m. on the
business day following the calendar day on which the purchase
occurs.
The Company will make further
announcements in due course following the completion of any
repurchases. There is no guarantee that the Programme will be
implemented in full or that any Ordinary Shares will be repurchased
by the Company.
The Company confirms that it
currently has no unpublished price sensitive
information.
- Ends -
For
further information please contact:
Spire Healthcare
Harbant Samra,
CFO
+44 (0)7881 672 365
Instinctif Partners
Julian
Walker
+44 (0)7825 189 696
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number
09084066
About Spire Healthcare
Spire
Healthcare is a leading
independent healthcare group in the United Kingdom, running 38
hospitals and over 50 clinics, medical centres and consulting rooms
across England, Wales and Scotland. It operates a network of
private GPs and provides occupational health services to over 800
corporate clients.
Working in partnership with over
8,600 experienced consultants, Spire Healthcare delivered tailored,
personalised care to over 1 million inpatients, outpatients and
daycase patients, and occupational health programme clients, in
2023, and is the leading private provider, by volume, of
knee and
hip operations in the United
Kingdom. It also delivers a range of private and NHS mental health,
musculoskeletal and dermatological services under the Vita Health
Group brand.
Spire Healthcare's well-located and
scalable hospitals have delivered successful and award-winning
outcomes, positioning the group well with patients, consultants,
the NHS, GPs and Private Medical Insurance ('PMI') providers. 98%
of Spire Healthcare's inspected locations are rated 'Good',
'Outstanding' or the equivalent by health inspectors in England,
Wales and Scotland.
Spire Healthcare is listed on the
London Stock Exchange and is a member of the FTSE 250.
